Noble Roman's, Inc.
NROM · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 8.5% | 1.7% | -4.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 34.4% | 27.4% | 32.8% | 28.1% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 25.7% | 18.4% | 7.6% | 18.2% |
| Net Income | $0 | $0 | -$0 | $0 |
| % Margin | 9.1% | 3.5% | -4.5% | 5% |
| EPS Diluted | 0.015 | 0.005 | -0.009 | 0.008 |
| % Growth | 184.6% | 161.2% | -206.3% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |